Eagle Health Investments LP
CIK 1842545
13F filing for Q2 2026・No. 3,502
- Holdings
- US$603.31M
- Quarter change
- +US$31.52M
- Entries
- 27
- Net bought (estimate)
- +US$590.84K
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 6
- Sold out 5
- Cut 4
- Added 9
- Corporate actions 0
- Unchanged 8
Largest holdings
27 stocks worth US$603.31M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| ARGXARGENX SESPONSORED ADR | Added | 76,417 | US$70.9M | 11.75% |
| ICON PUB LTD COSHS | Cut | 308,143 | US$53.53M | 8.87% |
| GHGUARDANT HEALTH INCCOM | Cut | 300,685 | US$45.11M | 7.48% |
| INSMINSMED INCCOM PAR $.01 | Added | 384,130 | US$40.96M | 6.79% |
| BMRNBIOMARIN PHARMACEUTICAL INCCOM | Added | 624,676 | US$35.74M | 5.92% |
| ILMNILLUMINA INCCOM | Unchanged | 187,413 | US$32.95M | 5.46% |
| SCHOLAR ROCK HLDG CORPCOM | Added | 555,272 | US$30.54M | 5.06% |
| PTGXPROTAGONIST THERAPEUTICS INCCOM | Added | 248,322 | US$30.44M | 5.05% |
| RAREULTRAGENYX PHARMACEUTICAL INCOM | Unchanged | 884,121 | US$29.52M | 4.89% |
| CMPSCOMPASS PATHWAYS PLCSPONSORED ADS | Unchanged | 2,060,427 | US$29.16M | 4.83% |
Sign in (free) to see its 27 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 10, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.